1. Home
  2. IOVA vs NUWE Comparison

IOVA vs NUWE Comparison

Compare IOVA & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.67

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Logo Nuwellis Inc.

NUWE

Nuwellis Inc.

HOLD

Current Price

$2.06

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
NUWE
Founded
2007
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
968.6M
2.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IOVA
NUWE
Price
$2.67
$2.06
Analyst Decision
Buy
Analyst Count
12
0
Target Price
$10.45
N/A
AVG Volume (30 Days)
12.3M
40.7K
Earning Date
02-26-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$250,425,000.00
$8,167,999.00
Revenue This Year
$60.71
N/A
Revenue Next Year
$59.52
$10.48
P/E Ratio
N/A
N/A
Revenue Growth
175.62
N/A
52 Week Low
$1.64
$1.71
52 Week High
$7.78
$70.14

Technical Indicators

Market Signals
Indicator
IOVA
NUWE
Relative Strength Index (RSI) 56.95 44.01
Support Level $2.69 $1.71
Resistance Level $2.89 $2.20
Average True Range (ATR) 0.20 0.15
MACD -0.01 0.01
Stochastic Oscillator 57.53 48.67

Price Performance

Historical Comparison
IOVA
NUWE

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Share on Social Networks: